（Years ended/ending March 31, million yen）
|
2025 3Q (9 months) |
2026 3Q (9 months) |
YoY (%) |
|
|
Domestic Sales |
101,153 |
100,192 |
-0.9 |
|
Overseas Sales (Overseas Sales Ratio) |
57,323 (36.2%） |
63,820 （38.9%） |
11.3 |
|
North America |
30,323 |
35,180 |
16.0 |
|
Latin America |
3,580 |
3,412 |
-4.7 |
|
Europe |
9,018 |
9,922 |
10.0 |
|
Asia & Other |
14,400 |
15,305 |
6.3 |
2026 3Q (9 months) ended December 31, 2025
- Japan: The Company concentrated on enhancing sales activities which match each market; the acute care hospital market, the small and mid-sized hospital market, and the clinic market. The Company also focused on strengthening its marketing and service capabilities, creating customer value which contributed to improving medical safety, patient outcomes, and operating efficiency. Because capital expenditure in hospitals was cautious, domestic sales decreased, while the Company focused on strengthening its consumables and services business. Sales in the public hospital market decreased. Sales of AEDs in the PAD (public access defibrillation) market also decreased due to inventory adjustment at distributors. Sales in the university, private hospital, and clinic markets increased.
- International: Sales achieved double-digit growth, because sales in North America, Europe, and Asia & Other increased favorably. Overseas sales also increased favorably on a comparable basis excluding the currency effect and the impact of the consolidation of Ad-Tech. Sales in North America showed double-digit growth, posting a significant increase in sales of neurology products including Ad-Tech as well as favorable sales of ventilators and AEDs. Sales of Patient Monitors decreased compared to the strong growth in the same period of the previous fiscal year. Sales in Latin America decreased, mainly in Mexico. In the third quarter (three months), sales in Latin America increased year on year due to large orders in Paraguay. Sales in Europe increased favorably, especially in Italy, Turkey, and the Netherlands. Sales in Asia & Other increased favorably, mainly in Southeast Asia and the Middle East & Africa. In the third quarter (three months), sales in Asia & Other decreased year on year due to taking time to comply with laws and regulations.
